MBC
Showing 1 - 25 of 643
Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
Recruiting
- Metastatic Breast Cancer
- CellSearch Circulating Tumor Cells
-
Rochester, Minnesota
- +1 more
Dec 21, 2022
Metastatic Breast Cancer (MBC) Trial in Nanjing, Shanghai (Paclitaxel Polymeric Micelles for Injection, Eribulin Mesilate
Recruiting
- Metastatic Breast Cancer (MBC)
- Paclitaxel Polymeric Micelles for Injection
- +5 more
-
Nanjing, Jiangsu, China
- +2 more
Nov 21, 2023
Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaBiyun Wang, MD
Apr 5, 2023
Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and
Not yet recruiting
- Invasive Mammary Carcinoma
- Metastatic Breast Cancer
- Capecitabine
- +2 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jan 11, 2023
Innovatively Increasing PCP Prescribing of Buprenorphine:
Active, not recruiting
- Opioid Abuse and Addiction
- MBC4OUD
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Nov 8, 2022
Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)
Active, not recruiting
- Metastatic Breast Cancer (MBC)
-
Basking Ridge, New Jersey
- +4 more
Oct 31, 2022
Male Breast Cancer Patients at Methodist Health System
Recruiting
- Male Breast Cancer Patients
- managing Male Breast Cancer Patients at Methodist Health System
-
Dallas, Texas
- +1 more
Nov 13, 2023
Implicit Bias Trial in Seattle (Brief Online Training (BOLT) for measurement-based care (MBC), Virtual Implicit Bias Reduction
Recruiting
- Implicit Bias
- Brief Online Training (BOLT) for measurement-based care (MBC)
- +3 more
-
Seattle, WashingtonUniversity of Washington
Jul 30, 2023
Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)
Recruiting
- Breast Cancer
- Endocrine Therapy and a CDK 4/6 inhibitor
-
Baltimore, MarylandJohns Hopkins University
Jul 18, 2022
The Rechallenge of ADCs in MBC Patients
Active, not recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 5, 2022
CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent
Not yet recruiting
- Breast Cancer
- +3 more
- Different treatment regimens following progression on CDK4/6 inhibitors.
- (no location specified)
Sep 5, 2023
Invasive Breast Cancer, Metastatic Breast Cancer, HR-Positive Breast Cancer Trial in United States (Pembrolizumab, Sacituzumab
Recruiting
- Invasive Breast Cancer
- +3 more
- Pembrolizumab
- Sacituzumab Govitecan
-
Atlanta, Georgia
- +7 more
Nov 14, 2022
Detection and Analysis of MBC With Heterogeneous ER Expression
Active, not recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
May 30, 2022
Breast Cancer Stage IV Trial in Irvine (Gallium-68)
Recruiting
- Breast Cancer Stage IV
-
Irvine, CaliforniaHoag Memorial Hospital Presbyterian
May 26, 2023
Metastatic Breast Cancer Trial in Worldwide (Ixabepilone Injection)
Recruiting
- Metastatic Breast Cancer
- Ixabepilone Injection
-
Aalst, Belgium
- +11 more
Nov 28, 2022
Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,
Recruiting
- Premenopausal Breast Cancer
- +2 more
- Goserelin
- +3 more
-
Taipei City, TaiwanDepartment of Oncology, National Taiwan University Hospital
Feb 7, 2023
Health Behavior Trial in Benham (Stress Management Control, Adapted MBC2 Program)
Recruiting
- Health Behavior
- Stress Management Control
- Adapted MBC2 Program
-
Benham, KentuckyMBC2 Field Office
Jan 5, 2022
Among Brazil Receiving Palbociclib Combinations for HR+/HER2-
Recruiting
- Breast Cancer
- Breast Carcinoma
-
Brasilia, Distrito Federal, BrazilInstituto D´Or de Pesquisa E Ensino - Brasília
Aug 15, 2022
Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Boston (Cessation of anti-HER2 treatment)
Not yet recruiting
- Breast Cancer
- +2 more
- Cessation of anti-HER2 treatment
-
Boston, Massachusetts
- +1 more
Feb 9, 2023
Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,
Terminated
- Breast Neoplasms
- Malignant Tumor of the Breast
- Trastuzumab
- +2 more
-
Multiple Locations, Texas19 Sites
Nov 29, 2022
Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)
Not yet recruiting
- Locally Advanced Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
-
Cádiz, Andalucía, Spain
- +18 more
Feb 24, 2023
Fatigue, Metastatic Breast Carcinoma Trial in Pittsburgh (Apollo Armband)
Recruiting
- Fatigue
- Metastatic Breast Carcinoma
- Apollo Armband
-
Pittsburgh, PennsylvaniaMagee Womens Hospital
Jan 27, 2022